Kerstin Moehle

Kerstin Moehle

Auto-generated profile, based on publicly available information

Kerstin Moehle

Institute of Organic Chemistry University of Zürich Winterthurerstrasse 190 8057 Zürich (Switzerland) Fax: (+41) 1635‐6833

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
SVStefan U. Vetterli
Stefan U. Vetterli
KZKatja Zerbe
Katja Zerbe
MMMaik Müller
Maik Müller
MUMatthias Urfer
Matthias Urfer
MMMilon Mondal
Milon Mondal
JRJohn A. Robinson
John A. Robinson
With the increasing resistance of many Gram-negative bacteria to existing classes of antibiotics, identifying new paradigms in antimicrobial discovery is an important research priority. Of special interest are the proteins required for the biogenesis of the asymmetric Gram-negative bacterial outer membrane (OM). Seven Lpt proteins (LptA to LptG) associate in most Gram-negative bacteria to form a macromolecular complex spanning the entire envelope, which transports lipopolysaccharide (LPS) molecules from their site of assembly at the inner membrane to the cell surface, powered by adenosine 5′-triphosphate hydrolysis in the cytoplasm. The periplasmic protein LptA comprises the protein bridge across the periplasm, which connects LptB2FGC at the inner membrane to LptD/E anchored in the OM. We show here that the naturally occurring, insect-derived antimicrobial peptide thanatin targets LptA and LptD in the network of periplasmic protein-protein interactions required to assemble the Lpt complex, leading to the inhibition of LPS transport and OM biogenesis in Escherichia coli.

26 May 2023 in Science Advances
Verified
Journal Article
Open access
MSMatthias Schuster
Matthias Schuster
EBEmile Brabet
Emile Brabet
KOKathryn K. Oi
Kathryn K. Oi
NDNicolas Desjonquères
Nicolas Desjonquères
KMKerstin Moehle
Kerstin Moehle
OZOliver Zerbe
Oliver Zerbe
The rise of antimicrobial resistance poses a substantial threat to our health system, and, hence, development of drugs against novel targets is urgently needed. The natural peptide thanatin kills Gram-negative bacteria by targeting proteins of the lipopolysaccharide transport (Lpt) machinery. Using the thanatin scaffold together with phenotypic medicinal chemistry, structural data, and a target-focused approach, we developed antimicrobial peptides with drug-like properties. They exhibit potent activity against Enterobacteriaceae both in vitro and in vivo while eliciting low frequencies of resistance. We show that the peptides bind LptA of both wild-type and thanatin-resistant Escherichia coli and Klebsiella pneumoniae strains with low-nanomolar affinities. Mode of action studies revealed that the antimicrobial activity involves the specific disruption of the Lpt periplasmic protein bridge.

16 February 2000 in Helvetica Chimica Acta
Verified
Journal Article
Closed access
PDF file
MPMarc E. Pfeifer
Marc E. Pfeifer
KMKerstin Moehle
Kerstin Moehle
ALAnthony Linden
Anthony Linden
JRJohn Robinson
John Robinson

2 April 2002 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
RMRafael Moreno
Rafael Moreno
LJLuyong Jiang
Luyong Jiang
KMKerstin Moehle
Kerstin Moehle
RZRinaldo Zurbriggen
Rinaldo Zurbriggen
RGReinhard Glück
Reinhard Glück
GPGerd Pluschke
Gerd Pluschke

5 November 2001 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
RMRafael Moreno
Rafael Moreno
LJLuyong Jiang
Luyong Jiang
KMKerstin Moehle
Kerstin Moehle
RZRinaldo Zurbriggen
Rinaldo Zurbriggen
RGReinhard Glück
Reinhard Glück
GPGerd Pluschke
Gerd Pluschke